Human IFN-γ T cell ELISPOT kit - 2-plate

SKU
CT230-B2
All-inclusive ELISPOT kit with reagents and plates (192 determinations).
Format
2-plate
Price
€ 485
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assays. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, Tween-20, and high-quality PVDF ELISPOT plates with lids and adhesive plate covers.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458
Related Products

References

Authors, et al. Title Journal Year Volume Pages
E James Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative Diabetes Metab Res Rev 2011 27 727-36
R Mallone Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative Diabetes Metab Res Rev 2011 27 720-6
B Brooks-Worrell Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls Diabetes Metab Res Rev 2011 27 737-45
P Eerligh Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes Genes Immun 2011 12 415-27
Sefina Arif Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death Diabetes 2011 60 2112-9
Emanuela Martinuzzi acDCs enhance human antigen-specific T-cell responses Blood 2011 118 2128-37
M Hemmati Expression and Purification of Recombinant Mycobacterium Tuberculosis (TB) Antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and Their Diagnosis Potential for Detection of TB Patients Iran Red Crescent Med J 2011 13 556-63
Jun Li Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection Virol J 2011 8 199
Chao Zheng Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese Diabetes Metab Res Rev 2011 27 70-8
R Mallone Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society Clin Exp Immunol 2011 163 33-49